• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Shorter antibiotic therapy for prosthetic joint infection caused worse outcomes

byRicha SharmaandHarsh Shah
June 25, 2021
in Infectious Disease, Orthopedic Surgery, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. A six-week antibiotic therapy was not shown to be non-inferior to a 12-week antibiotic therapy for patients with confirmed prosthetic joint infections.

2. The six-week therapy resulted in more unfavorable outcomes for patients compared to the 12-week therapy.

Evidence Rating Level: 1 (Excellent)   

Study Rundown: Treatment of prosthetic joint infections (PJI) is challenging and often involves surgery and antimicrobial therapy. These management options are expensive and have a high long-term failure rate. Furthermore, antibiotic therapy is based on expert recommendations rather than evidence, and treatment duration can last up to six months. Recent studies have proposed the use of shorter therapy durations to reduce adverse events. As such, this study compared the efficacy and safety of a six-week antibiotic treatment (short course) and a 12-week treatment (long course) in patients with PJI. The study determined the short course was not shown to be non-inferior to the long course. Furthermore, the short course caused more patients to experience unfavorable outcomes compared to the long course. This trial was limited by an open-label study design and more patients in the short-course group had undergone debridement with implant retention. Nonetheless, the results are significant, as the study determined a short antibiotic course was not appropriate for patients with PJI compared to the long antibiotic course.

Click to read the study in NEJM

Relevant reading: Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial

In-Depth [randomized controlled trial]: This open-label, randomized control trial enrolled 410 patients from 28 centers in France between November 2011 and January 2015. Patients included in the trial were 18 years of age or older, had a confirmed prosthetic joint infection, and a microbiologically documented infection. Patients who had received an effective antibiotic therapy 21 days before screening and had a lie expectancy of fewer than two years were excluded from the study. The patients were randomized in a 1:1 ratio to receive either a 6-week antibiotic course or a 12-week antibiotic course, respectively. Antibiotic therapy was defined as the administration of antibiotics for the type of bacteria causing the infection. The primary outcome was the events of treatment failure divided into three categories: persistent infection, new infection, and probable failure. In the short course group, 35 of 193 patients (18.1%) had persistent infection whereas, in the 12-week group, 18 of 191  patients (9.4%) displayed persistent infection (risk difference [RD], 8.7 percentage points; 95% confidence interval [CI], 1.8 to 15.6). This did not meet the criterion for noninferiority. Treatment failure occurred in 13 of 190 patients (6.8%) in the short course group for new infection compared to 20 of 188 patients (10.6%) in the long course (RD, -3.8 percentage points; 95% CI, -9.7 to 2.0). Additionally, probable treatment failure occurred in 8 of 192 patients (4.2%) in the short course group compared to 7 of 190 patients (3.7%) in the long course group (RD, 0.5 percentage points; 95% CI, -3.8 to 4.8). Finally, the most common adverse events related to the operative site, musculoskeletal events, cardiovascular events, and serious reactions to antibiotics. Overall, the study results did not show non-inferiority of the six-week antibiotic treatment as compared to the 12-week antibiotic treatment for patients with confirmed prosthetic joint infection.

RELATED REPORTS

#VisualAbstract: Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

#VisualAbstract: Shorter antibiotic therapy for prosthetic joint infection caused worse outcomes

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antibiotic therapynew infectionpersistent infectionprosthetic joint infectiontreatment failure
Previous Post

Bridging with low molecular weight heparin may not be beneficial for patients with atrial fibrillation or mechanical heart valves

Next Post

Lentiviral gene therapy treatment for adenosine deaminase deficiency

RelatedReports

#VisualAbstract: Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia
StudyGraphics

#VisualAbstract: Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

October 28, 2021
Prescription of antibiotics for acute respiratory infections increasing
Emergency

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

October 21, 2021
#VisualAbstract: Ziltivekimab antagonism of IL-6 reduces inflammation and thrombosis in patients with atherosclerotic risk factors
StudyGraphics

#VisualAbstract: Shorter antibiotic therapy for prosthetic joint infection caused worse outcomes

June 16, 2021
Total knee replacement with post-surgical regimen yields greater relief vs nonsurgical treatment alone
Chronic Disease

Shorter antibiotic therapy for prosthetic joint infection caused worse outcomes

June 8, 2021
Next Post
Non-invasive prenatal testing linked to decreased diagnostic testing

Lentiviral gene therapy treatment for adenosine deaminase deficiency

#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients

#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients

Few older adolescents meet recommended levels of physical activity

Consistent physical inactivity may increase the severity of COVID-19 infection

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events
  • Early onset Lewy Body Dementia is more clinically distinct from Alzheimer Dementia than late onset Lewy Body Dementia
  • Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.